The authors conducted a 2003–2007 case-control study including 184 cases and 194
controls to examine the association between blood lead and the risk of amyotrophic lateral …

Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates
lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that …

Background: Sodium-glucose cotransporter-2 inhibitors are foundational therapy in patients
with heart failure with reduced ejection fraction (HFrEF), but underlying mechanisms of …

Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social
salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) …

Haplotypes serve many useful roles in the design and implementation of genetic studies of
complex traits. In this chapter, we focus on the use of haplotypes as variables of interest for …

Introduction The prevalence of heart failure with preserved ejection fraction (HFpEF) is
increasing. This disease has posed diagnostic and therapeutic challenges; mortality and …

Introduction: Monogenic cardiovascular diseases (MCVDs) are collectively common yet
highly underdiagnosed. Genetic testing for pathogenic variants can facilitate diagnosis and …

Introduction: Changes in substrate utilization may be a biomarker of, or a contributor to,
heart failure with reduced ejection fraction (HFrEF). Previous work has described circulating …

Introduction: Metabolomic profiling may identify altered metabolic pathways underlying
atherosclerosis and myocardial ischemia. We hypothesized that organic acids, which report on …

Introduction: The genomic regulatory networks underlying the pathogenesis of acute coronary
syndrome (ACS) are incompletely understood. As intermediate traits, circulating protein …